MSB 1.02% 99.0¢ mesoblast limited

Hi JB1975- you refer to EAP patients and confounding variables....

  1. 2,666 Posts.
    lightbulb Created with Sketch. 1712
    Hi JB1975- you refer to EAP patients and confounding variables. My understanding is that the new potency data is generated only from the 001 clinical trial- which removes the confounding variables. If Si was allowed to submit real world evidence from EAP patients I can see your point. But I think it is purely potency data from an assay that was in place at the time the 001 trial was conducted.

    The trouble is (one of them - there are probably about three at least) EAP patients are treated at physician discretion - and physicians tend to treat their patients differently from one to another which introduces confounding variables.



    Reg

    Last edited by reginaldp: 11/04/24
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
99.0¢
Change
0.010(1.02%)
Mkt cap ! $1.130B
Open High Low Value Volume
99.5¢ $1.02 98.5¢ $5.507M 5.501M

Buyers (Bids)

No. Vol. Price($)
1 9996 99.0¢
 

Sellers (Offers)

Price($) Vol. No.
99.5¢ 18069 3
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.